chr4-1801580-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000142.5(FGFR3):​c.616-40T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.158 in 1,583,716 control chromosomes in the GnomAD database, including 23,141 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.21 ( 4667 hom., cov: 34)
Exomes 𝑓: 0.15 ( 18474 hom. )

Consequence

FGFR3
NM_000142.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.892

Publications

12 publications found
Variant links:
Genes affected
FGFR3 (HGNC:3690): (fibroblast growth factor receptor 3) This gene encodes a member of the fibroblast growth factor receptor (FGFR) family, with its amino acid sequence being highly conserved between members and among divergent species. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein would consist of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member binds acidic and basic fibroblast growth hormone and plays a role in bone development and maintenance. Mutations in this gene lead to craniosynostosis and multiple types of skeletal dysplasia. [provided by RefSeq, Aug 2017]
FGFR3 Gene-Disease associations (from GenCC):
  • achondroplasia
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, ClinGen, Genomics England PanelApp, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Crouzon syndrome-acanthosis nigricans syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen
  • hypochondroplasia
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, G2P, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
  • lacrimoauriculodentodigital syndrome 2
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Muenke syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, ClinGen, G2P
  • thanatophoric dysplasia type 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Genomics England PanelApp, Orphanet, ClinGen
  • thanatophoric dysplasia type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
  • camptodactyly-tall stature-scoliosis-hearing loss syndrome
    Inheritance: AR, AD, SD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, G2P, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen
  • severe achondroplasia-developmental delay-acanthosis nigricans syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), ClinGen
  • isolated brachycephaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • isolated plagiocephaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • LADD syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • LADD syndrome 1
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 4-1801580-T-C is Benign according to our data. Variant chr4-1801580-T-C is described in ClinVar as Benign. ClinVar VariationId is 255343.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.399 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FGFR3NM_000142.5 linkc.616-40T>C intron_variant Intron 5 of 17 ENST00000440486.8 NP_000133.1 P22607-1Q0IJ44

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FGFR3ENST00000440486.8 linkc.616-40T>C intron_variant Intron 5 of 17 5 NM_000142.5 ENSP00000414914.2 P22607-1

Frequencies

GnomAD3 genomes
AF:
0.214
AC:
32612
AN:
152088
Hom.:
4637
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.403
Gnomad AMI
AF:
0.109
Gnomad AMR
AF:
0.147
Gnomad ASJ
AF:
0.213
Gnomad EAS
AF:
0.0662
Gnomad SAS
AF:
0.202
Gnomad FIN
AF:
0.131
Gnomad MID
AF:
0.231
Gnomad NFE
AF:
0.142
Gnomad OTH
AF:
0.209
GnomAD2 exomes
AF:
0.160
AC:
31080
AN:
193970
AF XY:
0.160
show subpopulations
Gnomad AFR exome
AF:
0.403
Gnomad AMR exome
AF:
0.125
Gnomad ASJ exome
AF:
0.217
Gnomad EAS exome
AF:
0.0425
Gnomad FIN exome
AF:
0.133
Gnomad NFE exome
AF:
0.143
Gnomad OTH exome
AF:
0.165
GnomAD4 exome
AF:
0.152
AC:
217972
AN:
1431510
Hom.:
18474
Cov.:
39
AF XY:
0.154
AC XY:
109056
AN XY:
709838
show subpopulations
African (AFR)
AF:
0.417
AC:
13718
AN:
32908
American (AMR)
AF:
0.128
AC:
5115
AN:
39962
Ashkenazi Jewish (ASJ)
AF:
0.224
AC:
5711
AN:
25538
East Asian (EAS)
AF:
0.0942
AC:
3580
AN:
38010
South Asian (SAS)
AF:
0.212
AC:
17525
AN:
82818
European-Finnish (FIN)
AF:
0.135
AC:
6640
AN:
49012
Middle Eastern (MID)
AF:
0.249
AC:
1427
AN:
5722
European-Non Finnish (NFE)
AF:
0.140
AC:
154148
AN:
1098312
Other (OTH)
AF:
0.171
AC:
10108
AN:
59228
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
11872
23743
35615
47486
59358
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5656
11312
16968
22624
28280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.215
AC:
32699
AN:
152206
Hom.:
4667
Cov.:
34
AF XY:
0.211
AC XY:
15722
AN XY:
74434
show subpopulations
African (AFR)
AF:
0.404
AC:
16759
AN:
41512
American (AMR)
AF:
0.147
AC:
2246
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.213
AC:
740
AN:
3468
East Asian (EAS)
AF:
0.0664
AC:
344
AN:
5182
South Asian (SAS)
AF:
0.203
AC:
980
AN:
4832
European-Finnish (FIN)
AF:
0.131
AC:
1389
AN:
10622
Middle Eastern (MID)
AF:
0.231
AC:
68
AN:
294
European-Non Finnish (NFE)
AF:
0.142
AC:
9632
AN:
67980
Other (OTH)
AF:
0.209
AC:
442
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1251
2501
3752
5002
6253
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
322
644
966
1288
1610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.125
Hom.:
292
Bravo
AF:
0.226
Asia WGS
AF:
0.181
AC:
629
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.39
DANN
Benign
0.12
PhyloP100
-0.89
PromoterAI
-0.036
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2305183; hg19: chr4-1803307; COSMIC: COSV53402151; COSMIC: COSV53402151; API